Drugs / Zhenyuan capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04421287 | Jun 2020 → Jul 2021 | coronary artery disorder | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zhenyuan capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04421287 ↗ |